Searched for
CRO SECTOR
India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...- NHB probing Aavas Financiers over loan classification lapsesThe sector regulator has recalled refinancing support worth nearly Rs 500 crore —a punitive action that has set off a sweeping leadership o...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Donald Trump company to own Cryptocurrency token CRO. What we know so farDonald Trump Media said it plans to purchase $105 million worth of CRO. Yorkville said the total expected funding for the company's treasur...
- Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keenInvestors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...
- Mahindra Finance appoints Mahesh Rajaraman as CROMahindra & Mahindra Financial Services appoints Mahesh Rajaraman as Chief Risk Officer, replacing Mallika Mittal who resigned amid a fraud ...
- CRO market still very much untapped in India: Cyndrella CarvalhoIndian CROs and CDMOs are attracting a lot of attention as companies, such as Syngene, Suven, and Divis, create long-term relationships wit...
- RBI prescribes qualifications for MDs, WTDs of urban cooperative banksIt further said the MD/WTD should be a post graduate or have qualifications in finance discipline. He or she could be either chartered/cost...
- Genome Valley Research Platform to disrupt the CRO market, aimed at helping young biotech cosGVRP is being launched with a mission to offer a rather unique “plug and play” model for providing drug discovery services to young biotech...
- NHB orders home financiers to appoint risk officerThe regulator on Wednesday wrote a letter to these companies, stipulating the responsibilities of this senior executive. ET has viewed a co...
- RBI not in favour of special credit window for NBFCsRBI is not in favour of providing special credit window to NBFCs to tide over the liquidity crunch, sources say.
- India urged to review policy on CRO, refurbished goods importA US-based advocacy group of the IT sector today asked Obama Administration to encourage India to align its policy on Compulsory Registrati...
- GEPL Capital recommends 'subscribe' to Syngene International IPOSyngene International Ltd, a subsidiary of leading pharma major Biocon Ltd and India’s leading CRO, is planning to raise Rs 550 crore from ...
- Budget 2014: Increase healthcare expenditure to 2.5% of GDPAll in all one hopes to see a Pharma friendly budget that can truly unleash the potential of this sector and take India to the next level.
- Budget 2014: Government needs to invest $5 billion per year for next 5 years in biotech, recommends PwCThe consultancy firm has also asked the government to allocate Rs 500 crore each year from the R&D cess accessible by the Technology Develo...
- Inverted duty, infrastructure issues hurting IT hardware sector: ExpertsThe existing players are now hopeful of positive changes coming in as the new government headed by PM Narendra Modi settles down to tackle ...
- KKN Group forays into steel bizThe Rs450-croRs KKN Group of companies, which has a preence in edible oils through the Tripti and Sunshine brands, has diversified into the...
- Clinical research outsourcing yet to take offDespite the leap-frogging growth projections for the healthcare-linked business, lack of awareness, infrastructure bottleneck and crunch in...
- Manpower crunch, lack of awareness affect CROClinical research outsourcing (CRO), touted as the next big think on the outsourcing sphere, is yet to take off.
- Clinical research in India needs 12,000 extra handsAmidst the euphoria over explosive growth story, India’s clinical research sector is braving an alarming manpower shortage.
Load More
